Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Thiazide Diuretics for Preventing Recurrent Calcium Kidney Stones

Mechanism of Action and Clinical Evidence

  • The American Urological Association recommends thiazide diuretics for patients with high or relatively high urine calcium and recurrent calcium stones, with a Grade B evidence strength, due to their ability to reduce urinary calcium excretion 1
  • Thiazide diuretics, such as hydrochlorothiazide, reduce urinary calcium excretion effectively at doses of 25 mg orally twice daily or 50 mg orally once daily, and are recommended by the American College of Physicians as effective pharmacological monotherapy for preventing recurrent nephrolithiasis 1

Important Clinical Considerations

  • Dietary sodium restriction must be continued when thiazides are prescribed to maximize the hypocalciuric effect and limit potassium wasting, with a recommended sodium intake of 2,300 mg daily 2
  • The hypocalciuric effect of thiazides may be more pronounced in women, due to a 2-fold higher expression of the thiazide-sensitive Na+-Cl− cotransporter in the apical membrane of the distal convoluted tubule in females 3
  • Thiazides should not be routinely administered in patients with Bartter syndrome, despite their hypocalciuric effect, as they may lead to life-threatening hypovolemia in these salt-wasting patients 4